SCREENING FOR EARLY FAMILIAL OVARIAN-CANCER WITH TRANSVAGINAL ULTRASONOGRAPHY AND COLOR BLOOD-FLOW IMAGING

被引:168
作者
BOURNE, TH
CAMPBELL, S
REYNOLDS, KM
WHITEHEAD, MI
HAMPSON, J
ROYSTON, P
CRAYFORD, TJB
COLLINS, WP
机构
[1] KINGS COLL,SCH MED & DENT,DEPT OBSTET & GYNAECOL,LONDON SE5 8RX,ENGLAND
[2] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED PHYS,LONDON W12 0NN,ENGLAND
关键词
D O I
10.1136/bmj.306.6884.1025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-To assess the value of transvaginal ultrasonography with colour blood flow imaging in detecting early ovarian cancer in women with a family history of the disease. Design-Study of self referred symptomless women with a close relative who had developed the disease. Each woman was screened to detect persistent lesions and defined changes in ovarian volume. Morphological score and pulsatility index were recorded. Setting-Ovarian screening clinic. Subjects-1601 self referred women. Interventions-Women with a positive screening result were recommended to have further investigations. Main outcome measures-Findings at surgery and histology of abnormal ovaries. Morphological score greater-than-or-equal-to 5 and pulsatility index < 1.0 at last scan. Results-Women were aged 17 to 79 (mean 47) years; 959 (60%) were premenopausal, 469 (29%) were naturally postmenopausal, and 173 (11%) had had a hysterectomy. 157 women had a pedigree suggestive of the site specific ovarian cancer syndrome and 288 of multiple site cancers. 61 women had a positive screening result (3.8%, 95% confidence interval 2.9 to 4.9%), six of whom had primary ovarian cancer detected at surgery (five stage Ia, one stage III). Use of a high morphological score or a low pulsatility index increased the odds of finding ovarian cancer from 1:9 to about 2:5 (1:1 in the highest risk groups). Five interval cancers were reported (three ovarian and two peritoneal). Eight of the 11 cancers developed in women with pedigrees suggestive of inherited cancer. Conclusions-Transvaginal ultrasonography with colour flow imaging can effectively detect early ovarian cancer in women with a family history of the disease. The screening interval should be less than two years.
引用
收藏
页码:1025 / 1029
页数:5
相关论文
共 29 条
  • [21] SASSONE AM, 1991, OBSTET GYNECOL, V78, P70
  • [22] Serov S., 1973, INT HISTOLOGICAL CLA, V9
  • [23] REVISED FIGO STAGING FOR GYNECOLOGICAL CANCER
    SHEPHERD, JH
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1989, 96 (08): : 889 - 892
  • [24] VANNAGELL JR, 1991, CANCER, V68, P458, DOI 10.1002/1097-0142(19910801)68:3<458::AID-CNCR2820680303>3.0.CO
  • [25] 2-3
  • [26] VANNAGELL JR, 1990, CANCER, V65, P573, DOI 10.1002/1097-0142(19900201)65:3<573::AID-CNCR2820650331>3.0.CO
  • [27] 2-4
  • [28] WEINER Z, 1992, OBSTET GYNECOL, V79, P159
  • [29] ADJUVANT THERAPY IN STAGE-I AND STAGE-II EPITHELIAL OVARIAN-CANCER - RESULTS OF 2 PROSPECTIVE RANDOMIZED TRIALS
    YOUNG, RC
    WALTON, LA
    ELLENBERG, SS
    HOMESLEY, HD
    WILBANKS, GD
    DECKER, DG
    MILLER, A
    PARK, R
    MAJOR, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (15) : 1021 - 1027